|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print August 4, 2006
Pharmacology, Pennsylvania State College of Medicine, Hershey, PA 17033
Corresponding Author: kmm15{at}psu.edu
Since increased TGF
J. Biol. Chem, 10.1074/jbc.M600579200
Submitted on January 19, 2006
Revised on August 2, 2006
Accepted on August 4, 2006
Requirement of Smad3 and CREB-1 in mediating TGF
induction of TGF
3 secretion
production by tumor cells contributes to cancer progression through paracrine mechanisms, identification of critical points that can be targeted to block TGF
production is important. Previous studies have identified the precise signaling components and promoter elements required for TGF
induction of TGF
1 expression in epithelial cells (J. Biol. Chem. 275, 30765-30773, 2000). In order to determine how regulation of TGF
3 expression differs from that of TGF
1, we identified the precise signaling pathways and transcription factor binding sites that are required for TGF
3 gene expression. Using mutational analysis in electrophoresis mobility shift assays (EMSAs), we demonstrated that the c-AMP-responsive element (CRE) site in the TGF
3 promoter was required for TGF
-inducible TGF
3 expression. EMSA supershift assays indicated that CRE binding protein 1 (CREB1) and Smad3 were the major components present in this TGF
-inducible complex. Further, using chromatin immunoprecipitation (ChIP) assays, we demonstrated that CREB-1, ATF-2, and c-Jun bound constitutively at the TGF
3 promoter (100 to +1), whereas Smad3 bound at this site only after TGF
stimulation. In addition, inhibition of Jun N-terminal kinase (JNK) and p38 suppressed TGF
induction of TGF
3 transactivation, while inhibition of extracellular signal-regulated kinase (ERK) and protein kinase A (PKA) had no effect. Small interfering RNA (siRNA)-CREB1 and siRNA-Smad3 significantly inhibited TGF
stimulation of TGF
3 promoter reporter activity and TGF
3 production. Our results indicate that TGF
activation of the TGF
3 promoter CRE site, which leads to TGF
3 production, is required TGF
RII, JNK, p38, and Smad3, but was independent of PKA, ERK, and Smad4.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D.-W. Lin, I.-C. Chang, A. Tseng, M.-L. Wu, C.-H. Chen, C. A. Patenaude, M. D. Layne, and S.-F. Yet Transforming Growth Factor {beta} Up-regulates Cysteine-rich Protein 2 in Vascular Smooth Muscle Cells via Activating Transcription Factor 2 J. Biol. Chem., May 30, 2008; 283(22): 15003 - 15014. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Gaide Chevronnay, P. B. Cornet, D. Delvaux, P. Lemoine, P. J. Courtoy, P. Henriet, and E. Marbaix Opposite Regulation of Transforming Growth Factors-{beta}2 and -{beta}3 Expression in the Human Endometrium Endocrinology, March 1, 2008; 149(3): 1015 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jin, W. Ding, and K. M. Mulder Requirement for the Dynein Light Chain km23-1 in a Smad2-dependent Transforming Growth Factor-beta Signaling Pathway J. Biol. Chem., June 29, 2007; 282(26): 19122 - 19132. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Yoon, R. Pogue, D. A. Ovchinnikov, I. Yoshii, Y. Mishina, R. R. Behringer, and K. M. Lyons BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways Development, December 1, 2006; 133(23): 4667 - 4678. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |